BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1571904)

  • 1. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313.
    Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim HM; Byhardt RW; Rubin P; Ortiz HG
    Cancer; 1992 Jun; 69(11):2744-8. PubMed ID: 1571904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
    Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
    Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim H; Rubin P; Ortiz H
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1191-5. PubMed ID: 2045293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Johnson CR; Schmidt-Ullrich RK; Wazer DE
    Cancer; 1992 Jun; 69(11):2749-54. PubMed ID: 1571905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.
    Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
    Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
    Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: a study of surgical margins.
    Lee JG
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(1):ORL49-53. PubMed ID: 4813646
    [No Abstract]   [Full Text] [Related]  

  • 10. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned preoperative irradiation and surgery for advanced cancer of the oral cavity, pharynx and larynx.
    Roswit B; Spiro RH; Kolson H; Lin PY
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):59-62. PubMed ID: 5009416
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. (Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group).
    Kramer S
    Can J Otolaryngol; 1975; 4(2):213-8. PubMed ID: 1139418
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple fractions in the treatment of head and neck cancer.
    Lindup R
    Clin Oncol (R Coll Radiol); 1992 Sep; 4(5):280-3. PubMed ID: 1390341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
    Marcial VA; Pajak TF; Chang C; Tupchong L; Stetz J
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):41-7. PubMed ID: 3542916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
    Wang CC; Efird J; Nakfoor B; Martins P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
    Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early response of oral, oropharyngeal, hypopharyngeal and laryngeal cancer related to local control and survival.
    Dawes PJ
    Br J Cancer Suppl; 1980 Apr; 4():14-6. PubMed ID: 6932917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of different variants of hyperfractionated irradiation in cancer of the naso- and oropharynx and of the oral mucosa].
    Aliev BM; Chuprik-Malinovskaia TP; Aleknavichius EE
    Med Radiol (Mosk); 1988 Jun; 33(6):37-41. PubMed ID: 3386429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.